The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study

OBJECTIVES: Owing to novel therapy strategies in epidermal growth factor receptor (EGFR)-mutated patients, molecular analysis of the EGFR and KRAS genome has become crucial for routine diagnostics. Till date these data have been derived mostly from clinical trials, and thus collected in pre-selected...

Descripción completa

Detalles Bibliográficos
Autores principales: Boch, Christian, Kollmeier, Jens, Roth, Andreas, Stephan-Falkenau, Susann, Misch, Daniel, Grüning, Wolfram, Bauer, Torsten Thomas, Mairinger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641502/
https://www.ncbi.nlm.nih.gov/pubmed/23558737
http://dx.doi.org/10.1136/bmjopen-2013-002560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641502/
https://www.ncbi.nlm.nih.gov/pubmed/23558737
http://dx.doi.org/10.1136/bmjopen-2013-002560

Ejemplares similares